Status:
COMPLETED
Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke
Lead Sponsor:
China Medical University Hospital
Conditions:
Stroke
Hemorrhagic Transformation Due to Acute Stroke
Eligibility:
All Genders
30-75 years
Phase:
PHASE2
Brief Summary
Astragalus membranaceus (AM) is used to treat stroke for a long period, and a number of studies have known that AM can reduce cerebral infarction area and has anti-oxidation. Hemorrhagic stroke will i...
Eligibility Criteria
Inclusion
- female or male;
- aged between 30 and 75 years;
- randomized allocation to a study group within 24 hours of hemorrhagic stroke onset;
- this was the patient's first hemorrhagic stroke, and the location of hemorrhage was the putamen;
- treatment may or may not have been included surgery; and
- the subject or their legal representative gave written informed consent to participate.
Exclusion
- recent thrombolysis treatment;
- history of previous stroke;
- full-dose or long-term anti-coagulation therapy;
- hemorrhagic stroke but the location was not putamen;
- coexisting systemic diseases such as terminal cancer, renal failure, liver cirrhosis, severe dementia, or psychosis;
- participation in another clinical trial within the last three months; and
- pregnancy or lactation.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01428401
Start Date
January 1 2008
End Date
March 1 2011
Last Update
September 5 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.